Updates are available Correction dated 2023-12-09

Article History

Received: 5 August 2023

Accepted: 21 September 2023

First Online: 13 October 2023

Change Date: 9 December 2023

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s12325-023-02740-6

Declarations

:

: Anikó Maráz has served in consulting or advisory roles for Merck & Co., Kenilworth, NJ, and the healthcare business of Merck KGaA, Darmstadt, Germany, and has provided speaker services for Bristol Myers Squibb, Merck & Co., Kenilworth, NJ, Roche, and the healthcare business of Merck KGaA, Darmstadt, Germany. Bence Nagy, Tamara Macher, and József Jeskó have served in consulting or advisory roles for the healthcare business of Merck KGaA, Darmstadt, Germany, for their work on this study. Erika Tischler and Csaba Csongvai are employees of Merck Kft., Budapest, Hungary, an affiliate of Merck KGaA, Darmstadt, Germany. Mairead Kearney is an employee of the healthcare business of Merck KGaA, Darmstadt, Germany, and reports stock and other ownership interests in Merck KGaA, Darmstadt, Germany, Novartis, and UCB Biopharma SPRL.

: Ethics approval, as required by Ministerial Decree No. 23/2002 (V.9) for non-interventional studies, was provided by the Hungarian Medical Research Council (No. IV/7775–4/2021/EKU) [CitationRef removed]. The NHIFA database was accessed under license and is not publicly available. Patient claims data received from the NHIFA database were anonymized.